Nifty wavers in early trade with positive bias, suggesting that bullish consolidation may remain the dominant theme in what’s likely to be a choppy, range-bound session.
Nifty (+32, 26018)
Sensex (+111, 85217)
Bank Nifty (-21, 59323)
NIFTY (CMP 26018):
SUPPORT: 25871/25703
RESISTANCE: 26157/26327
RANGE: 25900-26100
BIAS: Neutral
SECTOR GAINER:
NIFTY IT (+0.86%)
NIFTY METAL (+0.43%)
NIFTY AUTO(+0.37)
SECTOR LOSER:
NIFTY MEDIA (-0.47%)
NIFTY CON DURABLES (-0.36%)
NIFTY HEALTH INDEX (-0.25%)
STOCKS IN SPOTLIGHT:
1) Commanding attention are reports that Russian President Vladimir Putin is expected to arrive in New Delhi at around 4:30 PM on Thursday, 4 December, according to news agency PTI.
Defence stocks are likely to remain in the spotlight as Russian President Vladimir Putin begins his first visit to India in four years.
The strategic dialogue is expected to centre around advanced defence cooperation, with particular focus on the S-500 Prometheus missile system, a next-generation upgrade over the S-400 platform currently being inducted.
During discussions with Russian Defence Minister Andrey Belousov, the Indian delegation is expected to emphasize timely delivery of pending military hardware, while also exploring options for future procurement, including the S-500, as widely reported in the media.
Bottom line: Heightened geopolitical engagement and potential big-ticket defence deals could keep sentiment buoyant across defence manufacturing and allied sectors.
(Source: liveMint)
2) Interglobal Aviation (-2.21%, 5472) tumbles after IndiGo cancelled over 100 flights on December 3, 2025, across major airports — Delhi, Mumbai, Hyderabad, Bengaluru — with scores of additional delays.
The root cause: a combination of factors — primarily a crew shortage triggered by new regulatory norms on flight-duty time (FDTL), which came into effect recently.
(Source: thefederal.com)
Indian Energy Exchange (IEX) (+0.89%, 150) continues to trade with positive bias as the firm has achieved monthly electricity traded volume (excluding TRAS) of 11,409 MU in November’25, marking an 17.7% increase on year-on-year basis.
3) Key Positive Catalysts for IEX
a) Strong Volume Momentum:
IEX clocked 11,409 MU of electricity traded volume (ex-TRAS) in November 2025, marking a robust 17.7% YoY growth — reinforcing sustained demand recovery and improved market liquidity.
b) Rising Short-Term Power Demand:
Higher industrial activity, early winter load pickup, and continued supply constraints in certain regions are pushing more participants toward short-term power markets, directly benefiting IEX’s core trading volumes.
c) Improving Market Participation:
Increasing buyer participation from state distribution companies and large commercial/industrial consumers is strengthening price discovery and boosting day-ahead and real-time market volumes.
(Source: CNBCTV18)
4) Biocon Limited (-2.93%, ₹398) surrendered all of its recent gains after news broke that the company’s Board will meet on Saturday, December 6, 2025, to evaluate key strategic proposals that could significantly influence its growth trajectory and shareholder value.
The marquee agenda item is a potential capital infusion into Biocon Biologics, the company’s unlisted biosimilars arm. The proposal — likely via direct cash investment or preferential allotment — aims to strengthen Biocon’s stake while ensuring adequate capital for long-term expansion, regulatory filings, and global commercial rollout plans.
This development comes on the heels of a major breakthrough for Biocon Biologics, which has signed a settlement agreement with Amgen Inc. The deal clears the pathway for the commercialization of its Denosumab biosimilars — Vevzuo and Evfraxy — across Europe starting December 2, 2025, with additional global markets set to open up thereafter. Although financial and commercial terms remain undisclosed, the settlement is widely seen as a meaningful step in unlocking value from the biosimilars franchise.
However, despite strong fundamentals, today’s correction indicates that investors remain cautious ahead of the Board’s decision, with concerns centered around near-term dilution, funding structure, and the potential impact on Biocon’s balance sheet.
(Source: Moneycontrol)
KEY THEMES FOR THE DAY:
1) A key RBI policy decision and US payrolls on December 5 — potentially a major volatility trigger.
2) Geopolitics enters the frame with Putin’s India visit (Dec 4–5),
Top Index Gainers:
TCS (+1.19%)
HCLTECH (+1.03%)
EICHERMOT (+0.88%)
HINDALCO (+0.70%)
JSWSTEEL (+0.65%)
Top Index Losers:
INDIGO (-1.07%)
HINDUNILVR (-0.94%)
TITAN (-0.72%)
HDFCLIFE (-0.63%)
POWERGRID (-0.63%)
10:00 AM GLOBAL UPDATE:
Dow Futures: (+77, 47960)
Nasdaq 100 Futures (-10, 25597)
Nikkei (+655, 50520)
Hang Seng (+56, 25816)
Dollar Index (+0.11%, 99.01)
WTI OIL (+0.13%, 59.26)
Gold (-7, 4196)
Securities in Ban for Trade Date: Thursday, December 4th 2025
SAMMAANCAP
Disclaimer/ Disclosure: The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.